0
Skip to Content
Percassist
Percassist
Need
Solution
Company
Team
News
Contact
Percassist
Percassist
Need
Solution
Company
Team
News
Contact
Need
Solution
Company
Team
News
Contact

PercAssist, Inc.
2374 Walsh Avenue,
Santa Clara, CA 95051

References:   

Vahdatpour C, Collins D, Goldberg S. Cardiogenic Shock. J Am Heart Assoc. 2019;8(8):e011991.

Shaefi S, O'Gara B, Kociol RD, et al. Effect of cardiogenic shock hospital volume on mortality in patients with cardiogenic shock. J Am Heart Assoc. 2015;4(1):e001462.

Subramaniam AV, Barsness GW, Vallabhajosyula S, Vallabhajosyula S. Complications of Temporary Percutaneous Mechanical Circulatory Support for Cardiogenic Shock: An Appraisal of Contemporary Literature. Cardiol Ther. 2019;8(2):211-228.

* PercAssist internal market estimates based on incidence/growth data for cardiogenic shock and heart failure.

PercAssist eVAD™ and PercAssist eVAD™ System are trademarks of PercAssist, Inc.

The PercAssist eVAD™ System technology is under development and is for investigational use only.   Not yet approved by FDA and not available for commercial distribution in the United States or any other market.

© 2025 PercAssist, Inc.